Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

BAM15 could be an effective drug for treating obesity and related diseases

A new study offers the first evidence that a protein named BAM15 acts as an energy uncoupler and could be an effective drug for treating obesity and related diseases.

10 Jun 2020

Research team provides new insights on the communication between liver and brain

A research team in Vienna is investigating how calorie intake, liver activity and fat storage interact and what role the central nervous system plays in this.

10 Jun 2020

Study estimates health and economic impacts of the national menu calorie labeling law

The national law requiring chain restaurants to include calorie labels on menus is estimated to prevent tens of thousands of new heart disease and type 2 diabetes cases--and save thousands of lives--in just five years, according to a new study estimating the law's impact.

9 Jun 2020

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease.

9 Jun 2020

Study reveals essential components of dietary restriction

Studies by Monash Biomedicine Discovery Institute (BDI), have provided a new understanding into the roles two essential amino acids play in metabolic health, which may help scientists in the fight against obesity.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

A new study published on the preprint server medRxiv in June 2020 reports that one mechanism for this variable severity is the differential expression of the ACE2 receptor in various metabolic conditions, thereby facilitating viral entry into the host cells.

9 Jun 2020

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Dr. Leszek Ignatowicz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $1.95 million federal grant to study what causes autoimmunity in the human body.

8 Jun 2020

A New Era in Diabetes Care: Launch of new report

A new expert-led report has today been launched to help outline key challenges and inequalities in the care of type 2 diabetes mellitus (T2DM) and its associated renal and cardiovascular complications, and highlight some Calls to Action to try and address these gaps for the 53 million Europeans living with T2DM.

5 Jun 2020

New research focuses on protein-coding gene's role in inflammatory bowel disease

A protein-coding gene associated with autoimmune diseases such as Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease, or IBD, will be the focus of new research in the School of Medicine at the University of California, Riverside.

4 Jun 2020

How COVID-19 affects people with Down Syndrome

A new study published in June 2020 on the preprint online server medRxiv reports on the increased risk of COVID-19 in Down Syndrome (DS) and certain characteristic features that are found in this population segment.

3 Jun 2020

Cone snail venom produces new type of insulin

Diabetes is a global health issue affecting millions. In 2014, there were 422 million diabetics, compared to 108 million in 1989. The condition can be treated with diet, physical activity, medicines like synthetic insulin injections, and regular screening.

3 Jun 2020

Rigidity of tissues drives immune system activity, UCLA study finds

A UCLA research team has identified a new paradigm for understanding the regulation of the immune system, potentially paving the way for new approaches to treating infections and immune-related diseases such as type 1 diabetes and certain cancers.

2 Jun 2020

Study reveals how a fat cell's immune response worsens obesity

When obesity occurs, a person's own fat cells can set off a complex inflammatory chain reaction that can further disrupt metabolism and weaken immune response--potentially placing people at higher risk of poor outcomes from a variety of diseases and infections, including COVID-19.

2 Jun 2020

A satisfying romantic relationship predicts lower stress, inflammation in breast cancer survivors

Breast cancer survivors in romantic relationships who feel happy and satisfied with their partners may be at lower risk for a host of health problems, new research suggests.

2 Jun 2020

International research consortium launched to improve obesity treatment

University College Dublin (UCD) is leading SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), a new €16 million EU and industry supported international research consortium launched today.

2 Jun 2020

Cone snail insulin research could jumpstart the development of better diabetes treatments

Nearly a century after insulin was discovered, an international team of researchers including University of Utah Health scientists report that they have developed the world's smallest, fully functional version of the hormone, one that combines the potency of human insulin with the fast-acting potential of a venom insulin produced by predatory cone snails.

1 Jun 2020

Out-of-pocket health care costs for patients with type 1 diabetes is $2,500 a year, study reveals

Adults and children with type 1 diabetes will spend an average of $2,500 a year out-of-pocket for health care - but insulin isn't always the biggest expense - new research suggests.

1 Jun 2020

Researchers identify risk factors for fatty liver disease

Researchers at Massachusetts General Hospital have uncovered an unexpected connection between an imbalance of electrons in liver cells and many metabolic problems that increase the risk for conditions such as cardiovascular disease and fatty liver disease.

29 May 2020

NUTRITION 2020 LIVE ONLINE releases featured materials

Press materials are now available for NUTRITION 2020 LIVE ONLINE, a dynamic virtual event showcasing new research findings and timely discussions on food and nutrition. The online meeting will be held June 1-4, 2020.

29 May 2020

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

BAM15 could be an effective drug for treating obesity and related diseases

Research team provides new insights on the communication between liver and brain

Study estimates health and economic impacts of the national menu calorie labeling law

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

Study reveals essential components of dietary restriction

COVID-19 produces lung inflammation in non-human primate experiments

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

A New Era in Diabetes Care: Launch of new report

New research focuses on protein-coding gene's role in inflammatory bowel disease

How COVID-19 affects people with Down Syndrome

Cone snail venom produces new type of insulin

Rigidity of tissues drives immune system activity, UCLA study finds

Study reveals how a fat cell's immune response worsens obesity

A satisfying romantic relationship predicts lower stress, inflammation in breast cancer survivors

International research consortium launched to improve obesity treatment

Cone snail insulin research could jumpstart the development of better diabetes treatments

Out-of-pocket health care costs for patients with type 1 diabetes is $2,500 a year, study reveals

Researchers identify risk factors for fatty liver disease

NUTRITION 2020 LIVE ONLINE releases featured materials

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in